Medical Devices

Philip Morris International's upcoming Q1 2026 earnings will be a crucial test of its pivot from cigarettes, with all eyes on ZYN's growth and regulatory hurdles.

A new strategic deal for the Lasix ONYU device aims to secure its key ingredient, transforming heart failure care from the hospital to the living room.

With $108M in new funding, Terremoto Biosciences advances a novel class of drugs designed to overcome the toxicities of past cancer treatments.

With a fresh $28M investment, Verismo Therapeutics is set to unveil groundbreaking KIR-CAR data, aiming to revolutionize CAR T therapy for solid tumors.

Atelerix's revolutionary hydrogel eliminates the need for cold chain logistics, partnering with JH Health to unlock the booming Saudi biotech market.

A quiet law change has unleashed affordable, over-the-counter hearing aids in the UK, but as millions stand to benefit, experts urge caution.

The new CE-Marked iREACH IRIS provides surgeons with real-time tissue data and unprecedented maneuverability, aiming to reduce surgical complications.

Shanghai's SinoUnited Health is attracting global patients with advanced care like CAR-T therapy at a fraction of US prices, challenging medical tourism hubs.

New NCCN guidelines include AI mammogram analysis, a major shift to identify hidden breast cancer risks for millions of women missed by traditional methods.

Phase 3 data shows GTx-104 reduces key risks and improves outcomes for aSAH patients, positioning it as a potential new standard of care ahead of an FDA decision.

MeiraGTx will present 3-year data on a one-time therapy for radiation-induced dry mouth, a condition affecting millions of head and neck cancer survivors.

A son's concern for his mother sparks an investment in a startup using AI to combat the hidden dangers of chronic dehydration affecting millions.

Oxford spinout Caristo Diagnostics appoints Stephen Deitsch, who led a $1.5B exit, as CEO to accelerate its mission of preventing heart attacks with AI.

Harrow partners with specialist LogiCare3PL for U.S. distribution, highlighting an industry shift towards agile, high-touch logistics for faster market access.

As Ontario hospitals face a financial crisis, a major innovation week aims to connect Canadian startups with global capital to solve healthcare's biggest challenges.

Taiwanese biotech GlycoNex will begin human trials for GNX1021, a novel ADC that targets cancer's unique sugar coating to fight GI tumors.

Renaissance Pharma's Daretabart gains FDA support for high-risk neuroblastoma, accelerating its journey to patients and offering new hope against this rare disease.

A new report reveals a major gap in AI adoption as digital disruptors and generic GLP-1s force Canadian pharmacies to innovate or risk being left behind.

European non-profit ELRIG launches its first US conference, a free-to-attend event aiming to connect scientists and tackle intractable drug targets.

FDA clearance for a new neurovascular catheter promises greater precision and expands less invasive options for stroke and brain bleed procedures.